ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
Brain scans shows patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) share similar issues in a part of the brain known as the hippocampus.
Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 ...
Teledentistry is a technology-driven approach that enables remote consultations, diagnostics and patient education.
A mum-of-two has been fundraising for private medical treatment after being diagnosed with cancer. Hannah Quigley-McKie, from Stretford, Greater Manchester, booked an optician's appointment after ...
Credit Karolina Grabowska via PexelsThe first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been ...
A young Carlow woman suffering from Multiple Sclerosis (MS) said she is running out of time to access life-changing treatment in Mexico which she hopes will halt her MS from progressing any further ...
The patent application, filed under Application Number N2039644, represents a significant step forward in the Company's intellectual property strategy. This milestone highlights Cosmos Health's ...
Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results